Combination of integrin siRNA and irradiation for breast cancer therapy
Authors:
- Xiaoyuan ChenXCXiaoyuan Chen
- 1 December 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 351 (3) , 726-732
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (P50 CA114747, R21 CA102123, R24 CA93862, U54 CA119367)
- National Institute of Biomedical Imaging and Bioengineering (R21 EB001785)
- U.S. Department of War (DAMD17-03-1-0143, W81XWH-04-1-0697, W81XWH-06-1-0042, W81XWH-06-1-0665)
This publication has 19 references indexed in Scilit:
- Anti-Angiogenic Cancer Therapy Based on Integrin αvβ3 AntagonismAnti-Cancer Agents in Medicinal Chemistry, 2006
- Inhibition of αvβ3 Integrin Survival Signaling Enhances Antiangiogenic and Antitumor Effects of RadiotherapyClinical Cancer Research, 2005
- Irradiated C6 glioma cells induce angiogenesis in vivo and activate endothelial cells in vitroInternational Journal of Cancer, 2004
- Integrin αvβ3 as a Therapeutic Target for Blocking Tumor-Induced AngiogenesisCurrent Drug Targets, 2003
- IntegrinsCell, 2002
- Role of integrins in cell invasion and migrationNature Reviews Cancer, 2002
- Integrin activation controls metastasis in human breast cancerProceedings of the National Academy of Sciences, 2001
- RNA interference is mediated by 21- and 22-nucleotide RNAsGenes & Development, 2001
- Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegansNature, 1998
- Arg-Gly-Asp peptide increases endothelial hydraulic conductivity: comparison with thrombin responseAmerican Journal of Physiology-Cell Physiology, 1995